These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 2770004

  • 1. [Targeting of magnetically responsive drug carriers to cancer].
    Morimoto Y, Natsume H.
    Nihon Rinsho; 1989 Jun; 47(6):1432-6. PubMed ID: 2770004
    [No Abstract] [Full Text] [Related]

  • 2. Clinical applications of magnetic drug targeting.
    Lübbe AS, Alexiou C, Bergemann C.
    J Surg Res; 2001 Feb; 95(2):200-6. PubMed ID: 11162046
    [Abstract] [Full Text] [Related]

  • 3. Magnetic nanobeads decorated by thermo-responsive PNIPAM shell as medical platforms for the efficient delivery of doxorubicin to tumour cells.
    Deka SR, Quarta A, Di Corato R, Riedinger A, Cingolani R, Pellegrino T.
    Nanoscale; 2011 Feb; 3(2):619-29. PubMed ID: 21082085
    [Abstract] [Full Text] [Related]

  • 4. Intravesical administration of doxorubicin to swine bladder using magnetically targeted carriers.
    Leakakos T, Ji C, Lawson G, Peterson C, Goodwin S.
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):445-50. PubMed ID: 12802508
    [Abstract] [Full Text] [Related]

  • 5. Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK, Hung CT.
    J Microencapsul; 1990 Jun; 7(1):85-94. PubMed ID: 2308056
    [Abstract] [Full Text] [Related]

  • 6. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
    Wu XL, Kim JH, Koo H, Bae SM, Shin H, Kim MS, Lee BH, Park RW, Kim IS, Choi K, Kwon IC, Kim K, Lee DS.
    Bioconjug Chem; 2010 Feb 17; 21(2):208-13. PubMed ID: 20073455
    [Abstract] [Full Text] [Related]

  • 7. [Targeting therapy of cancer using monoclonal antibody-antitumor drug conjugate].
    Yachi A, Imai K, Hirata H, Hishikawa N.
    Nihon Rinsho; 1989 Jun 17; 47(6):1391-5. PubMed ID: 2475654
    [No Abstract] [Full Text] [Related]

  • 8. [Targeting technology utilizing magnetic microparticulate system for cancer therapy].
    Morimoto Y, Natsume H.
    Nihon Rinsho; 1998 Mar 17; 56(3):649-56. PubMed ID: 9549351
    [Abstract] [Full Text] [Related]

  • 9. [Drug delivery system of anticancer agent entrapped in temperature-sensitive liposomes combined with local hyperthermia].
    Takahashi T, Kumai K, Ishibiki K, Abe O, Tadakuma T, Yasuda T, Tomita T.
    Nihon Rinsho; 1989 Jun 17; 47(6):1408-11. PubMed ID: 2770001
    [No Abstract] [Full Text] [Related]

  • 10. Membrane alterations by liposomes to enhance clinical efficacy of cytotoxic drugs.
    Rahman A, Dusre L, Forst D, Thierry A, Roh JK, Greenspan A, Treat J.
    Prog Clin Biol Res; 1990 Jun 17; 343():281-304. PubMed ID: 2377628
    [No Abstract] [Full Text] [Related]

  • 11. [Targeting therapy of gastrointestinal cancers with sulfatide-inserted liposomes entrapping adriamycin].
    Yaguchi T, Yamauchi M, Nagata J, Takagi H, Hayashi Y, Ohishi S, Yagi K.
    Nihon Rinsho; 1989 Jun 17; 47(6):1369-72. PubMed ID: 2769998
    [No Abstract] [Full Text] [Related]

  • 12. Influence of a magnetic nanoparticle as a drug carrier on the activity of anticancer drugs: interactions of double stranded DNA and doxorubicin modified with a carrier.
    Nowicka AM, Kowalczyk A, Donten M, Krysinski P, Stojek Z.
    Anal Chem; 2009 Sep 01; 81(17):7474-83. PubMed ID: 19663451
    [Abstract] [Full Text] [Related]

  • 13. [Intracellular accumulation of free doxorubicin and doxorubicin encapsulated in nanospheres].
    Bogush TA, Smirnova GB, Shubina IZh, Bogush EA, Robert J.
    Biull Eksp Biol Med; 1994 Oct 01; 118(10):406-9. PubMed ID: 7865821
    [No Abstract] [Full Text] [Related]

  • 14. Vascular targeting as a strategy for cancer therapy.
    Schnitzer JE.
    N Engl J Med; 1998 Aug 13; 339(7):472-4. PubMed ID: 9700184
    [No Abstract] [Full Text] [Related]

  • 15. Characterization and pharmacokinetics of a novel pirarubicin liposome powder.
    Cong W, Liu Q, Chen X, Gao R, Lu J, Wang Y, Luo G.
    Drug Dev Ind Pharm; 2010 Oct 13; 36(10):1186-94. PubMed ID: 20515395
    [Abstract] [Full Text] [Related]

  • 16. Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas.
    Di Stefano G, Busi C, Fiume L, Chieco P, Pariali M.
    Dig Liver Dis; 2006 Apr 13; 38(4):284-5. PubMed ID: 16364702
    [No Abstract] [Full Text] [Related]

  • 17. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
    Munnier E, Cohen-Jonathan S, Linassier C, Douziech-Eyrolles L, Marchais H, Soucé M, Hervé K, Dubois P, Chourpa I.
    Int J Pharm; 2008 Nov 03; 363(1-2):170-6. PubMed ID: 18687392
    [Abstract] [Full Text] [Related]

  • 18. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
    Jain A, Agarwal A, Majumder S, Lariya N, Khaya A, Agrawal H, Majumdar S, Agrawal GP.
    J Control Release; 2010 Dec 20; 148(3):359-67. PubMed ID: 20854859
    [Abstract] [Full Text] [Related]

  • 19. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery.
    Guo M, Que C, Wang C, Liu X, Yan H, Liu K.
    Biomaterials; 2011 Jan 20; 32(1):185-94. PubMed ID: 21067808
    [Abstract] [Full Text] [Related]

  • 20. Iron oxide nanoparticles for sustained delivery of anticancer agents.
    Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V.
    Mol Pharm; 2005 Jan 20; 2(3):194-205. PubMed ID: 15934780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.